Surefire Medical has launched its new precision infusion system (PIS) at the Society for Interventional Radiology (SIR) meeting in Vancouver, Canada.

The new PIS features an increased length of 150cm and has a pressure rating of 1200 pounds per square inch (PSI).

It will allow additional access to the physicians during certain patient procedures and facilitates deeper penetration pressure for improved angiographic imaging.

The increased length of the PIS also enables physicians to employ the Surefire technology in radial artery access procedures which increases patient’s comfort, accelerates the recovery process and reduces the risk of any complications post-procedure.

The increased pressure rating of 1200PSI will help physicians to enhance the flow rate during infusion and is designed to improve angiographic visualisation.

The PIS with an increased pressure rating is also made available in the 120cm variant of the system.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
"Surefire Medical is pioneering site-specific drug delivery products that overcome the limitations of traditional tools and delivery methods."

Surefire Medical president and CEO James Chomas said: "Surefire Medical is pioneering site-specific drug delivery products that overcome the limitations of traditional tools and delivery methods.

"This 150cm precision system does just that, arming physicians who prefer radial access to target tumors and deliver therapies with superior accuracy, control and protection."

Surefire’s PIS isolates tumours in the patient by overcoming interstitial pressure to allow a deeper administration of the therapy while protecting the healthy tissues.

It has a thin texture and a pliable and segmented construction, along with a hydrophilic coating which reduces friction while being inserted into the patient’s system.

Image: An image of the extended precision infusion system. Photo: courtesy of Surefire Medical, Inc.